VEDBAEK, Denmark, May 31, 2011 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of an additional qPCR array for sensitive and specific quantification of 749 mouse and rat microRNAs.
With the launch of the new rodent qPCR array, Exiqon now offers two qPCR arrays for mouse and rat microRNAs in addition to the two qPCR arrays for human microRNAs. All qPCR arrays are based on LNA™ enhanced microRNA PCR primer sets and comprise more than 1,500 pre-validated assays making the qPCR assay offering the most comprehensive in the market.
"We have seen an increasing demand for a second mouse and rat qPCR array for genome wide screening and we are happy to have this product on the market today," said Senior Vice President Sales & Marketing, Dr. Henrik M. Pfundheller, and added: "All assays are validated against synthetic miRNA targets and tested for specificity and linear dynamic range of a minimum of 5 logs."
The extreme sensitivity obtained by inclusion of LNA™ in the PCR primers enables accurate microRNA profiling based on as little as 50 µl serum.
Exiqon's product line for microRNA qPCR also includes custom Pick & Mix ready-to-use 96- and 384-well panels, individual pre-validated and custom designed primer sets as well as RT and Master Mix kits and a qPCR data analysis software package.
Please see the full press release in the enclosed pdf-file.
Additional information:
Lars Kongsbak, President and CEO, tel. +45 4566 0888 (cell: +45 4090 2101)
Henrik M. Pfundheller, SVP Sales & Marketing, tel. +45 4565 0420 (cell: +45 4090 2106)
Attachments: